Device
Intacs
Intacs is a medical device with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
1(33%)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Terminated(1)
Detailed Status
Recruiting1
Terminated1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
recruiting133%
terminated133%
not_yet_recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
Clinical Trials (3)
Showing 3 of 3 trials
NCT02138669Not Applicable
Intacs Prescription Inserts for Keratoconus Patients
NCT02512432Not Applicable
INTACS (Intrastromal Corneal Ring Segments) For Corneal Ectasia
NCT00384501Not Applicable
Management of Patients With Keratoconus With Intacs
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3